Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methy transferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 6, 2009, Pages 667-672

  Jun, Dae Won ^a   Han, Jee Hye ^a   Jang, Eun Chul ^c   Kim, Sang Heum ^a   Kim, Seong Hwan ^a   Jo, Yoon Ju ^a   Park, Young Sook ^a   Chae, Jeong Don ^b,d  

^a Department of Internal Medicine ^*  (South Korea)

^b Eulji University School of Medicine   (South Korea)

^c Soonchunhyang University   (South Korea)

^d Eulji General Hospital   (South Korea)

Author keywords

Alcoholic fatty liver; Microsomal triglyceride transfer protein; Nonalcholic fatty liver; Polymorphism

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; DNA; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRINKING BEHAVIOR; FATTY ACID BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HEALTH PROMOTION; HUMAN; INSULIN BLOOD LEVEL; KOREA; LIPID METABOLISM; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANTHROPOMETRY; BODY MASS INDEX; CARRIER PROTEINS; FATTY LIVER; FATTY LIVER, ALCOHOLIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPIDS; LIVER; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; POLYMORPHISM, GENETIC;

EID: 67649649783     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283196adc     Document Type: Article

References (29)

1. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37:1202-1219.
2. Angulo P. Obesity and nonalcoholic fatty liver disease. Nutr Rev 2007; 65:S57-S63.
3. Collantes R, Ong JP, Younossi ZM. Nonalcoholic fatty liver disease and the epidemic of obesity. Cleve Clin J Med 2004; 71:657-664.
4. Martins A, Cortez-Pinto H, Machado M, Goncalves MS, Soren S, Marques-Vidal P, et al. Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease? Eur J Gastroenterol Hepatol 2005; 17:1099-1104.
5. Mern'man RB, Aouizerat BE, Bass NM. Genetic influences in nonalcoholic fatty liver disease. J Clin Gastroenterol 2006; 40:S30-S33.
6. Stickel F, Osterreicher CH. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 2006; 41:209-224.
7. Goldberg IJ, Ginsberg HN. Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Gastroenterology 2006; 130:1343-1346.
8. Newberry EP, Xie Y, Kennedy S, Han X, Buhman KK, Luo J, et al. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J Biol Chem 2003; 278:51664-51672.
9. Dong H, Wang J, Li C, Hirose A, Nozaki Y, Takahashi M, et al. The phosphatidylethanolamine W-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. J Hepatol 2007; 46:915-920.
10. Ledmyr H, Ottosson L, Sunnerhagen M, Ehrenborg E. The lle128Thr polymorphism influences stability and ligand binding properties of the microsomal triglyceride transfer protein. J Lipid Res 2006; 47:1378-1385.
11. Namikawa C, Shu-Ping Z, Vyselaar JR, Nozaki Y, Nemoto Y, Ono M, et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 2004; 40:781-786.
12. Romeo S, Cohen JC, Hobbs HH. No association between polymorphism in PEMT (V175M) and hepatic triglyceride content in the Dallas Heart Study. Faseb J 2006; 20:2180; author reply 2181-2182.
13. Song J, da Costa KA, Rscher LM, Kohlmeier M, Kwock L, Wang S, et al. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). Faseb J 2005; 19:1266-1271.
14. Herrmann SM, Poirier O, Nicaud V, Evans A, Ruidavets JB, Luc G, et al. Identification of two polymorphisms in the promoter of the microsomal triglyceride transfer protein (MTP) gene: lack of association with lipoprotein profiles. J Lipid Res 1998; 39:2432-2435.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function
16. from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
17. Grundy SM, Cleeman Jl, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752.
18. Ledmyr H, Karpe F, Lundahl B, McKinnon M, Skoglund-Andersson C, Ehrenborg E. Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. J Lipid Res 2002; 43:51-58.
19. Maheshwari A, Thuluvath PJ. Cryptogenic cirrhosis and NAFLD: are they related? Am J Gastroenterol 2006; 101:664-668.
20. Lorenzo A, Auguet T, Vidal F, Broch M, Olona M, Gutierrez C, et al. Polymorphisms of alcohol-metabolizing enzymes and the risk for alcoholism and alcoholic liver disease in Caucasian Spanish women. Drug Alcohol Depend 2006; 84:195-200.
21. Kim MS, Lee DH, Kang HS, Park HS, Jung S, Lee JW, et al. [Genetic polymorphisms of alcohol-metabolizing enzymes and cytokines in patients with alcohol induced pancreatitis and alcoholic liver cirrhosis]. Korean J Gastroenterol 2004; 43:355-363.
22. Gambino R, Cassader M, Pagano G, Durazzo M, Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology 2007; 45:1097-1107.
23. Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, et al. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 2006; 130:1661-1669.
24. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, Mason A, et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab 2006; 3:21-331.
25. Li Z, Agellon LB, Vance DE. Phosphatidylcholine homeostasis and liver failure. J Biol Chem 2005; 280:37798-37802.
26. Debongnie JC, Pauls C, Fievez M, Wibin E. Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Guf 1981; 22:130-135.
27. Foster KJ, Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980; 53: 440-442.
28. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43:26-31.
29. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986; 292:13-15.